Modaplex Platform

This proprietary platform enables the quantification of up to 2,000 DNA and RNA targets within 3.5 hours

Hemato-Oncology

Molecular diagnostics of Acute Myeloid Leukemia (AML) / Chimerism monitoring after allogenic stem cell transplantation

COVID-19 Assays

We are distributing kits for the detection of SARS-CoV-2 and other viruses. The kits are developed and owned by Primerdesign Ltd., situated in the UK.

Custom Solutions

Biotype’s contract development & manufacturing premium service covers all the challenges, right from the idea up to a marketable product

 

Modaplex closes diagnostic gap

We are expanding our product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation Sequencing.

Its unique combination of PCR amplification and parallel performed capillary electrophoresis enables the quantification of up to 50 DNA and/or RNA markers per sample within 3.5 hours. Explore all the additional advantages it creates for your molecular diagnostics, either for customized development, routine use, or for technology transfer.

Learn more

Events

33rd European Congress of Pathology
29th - 31st Aug 2021 / virtual

Deutsche Biotechnologietage 2021
20th – 21st September 2021 / Stuttgart

Modaplex KNB Mutation Analysis Kits

We launch 3 new assays on our molecular diagnostic platform ModaplexTM:

  • Modaplex KRAS Mutation Analysis Kit
  • Modaplex NRAS Mutation Analysis Kit
  • Modaplex BRAF Mutation Analysis Kit

The kits (research use only) enable the detection of 13 KRAS, 13 NRAS, and 4 BRAF (KNB) mutations together in a single run.

Learn more

Latest news

#SOLVECoV2: 10 Saxony biotech solutions to fight the pandemic

28-06-2021
Biotechnology and medical technology companies based in Saxony made a significant contribution to combating the corona pandemic.

Learn more